Demant sees window of opportunity as millions lack hearing aids due to Covid-19
New products have driven Demant’s 2021 growth, but this was just the beginning. The Covid-19 pandemic has made the normally predictable hearing aid market unpredictable, but Demant wants to capitalize on the pent-up demand.
by christian bundgaard, translated by catherine brett
For hearing aid manufacturers, 2020 and 2021 were like chalk and cheese.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Demant reports record operating result
For subscribers
Demant unveils parts of full-year report by mistake
For subscribers
